A PTEN-Autophagy Risk Model for the Prediction of Prognosis and Immune Microenvironment in Hepatocellular Carcinoma
Authors:
Open Access
- 20 February 2023
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2023, 1-15
Abstract
Background. The clinical behavior and molecular mechanisms of hepatocellular carcinoma (HCC) are complex and highly variable, limiting the discovery of new targets and therapies in clinical research. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is one of the tumor suppressor genes. It is of great interest to discover the role of unexplored correlation among PTEN, the tumor immune microenvironment, and autophagy-related signaling pathways and to construct a reliable risk model for prognosis during HCC progression. Method. We first performed differential expression analysis on the HCC samples. By using Cox regression and LASSO analysis, we determined the DEGs contributing to the survival benefit. In addition, the gene set enrichment analysis (GSEA) was performed to identify potential molecular signaling pathways regulated by the PTEN gene signature, autophagy, and autophagy-related pathways. ESTIMATE was also employed for evaluating the composition of immune cell populations. Results. We found a significant correlation between PTEN expression and the tumor immune microenvironment. The low-PTEN expression group had higher immune infiltration and lower expression of immune checkpoints. In addition, PTEN expression was found to be positively correlated with autophagy-related pathways. Then, differentially expressed genes between tumor and tumor-adjacent samples were screened, and 2895 genes were significantly associated with both PTEN and autophagy. Based on PTEN-related genes, we identified 5 key prognostic genes, including BFSP1, PPAT, EIF5B, ASF1A, and GNA14. The 5-gene PTEN-autophagy risk score (RS) model was demonstrated to have favorable performance in the prediction of prognosis. Conclusion. In summary, our study showed the importance of the PTEN gene and its correlation with immunity and autophagy in HCC. The PTEN-autophagy.RS model we established could be used to predict the prognosis of HCC patients and showed significantly higher prognostic accuracy than the TIDE score in response to immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (82160650, XJ2022G165)
- National Health Commission of the People's Republic of China (82160650, XJ2022G165)
- Autonomous Region Graduate Student Scientific Research Innovation Project (82160650, XJ2022G165)
This publication has 41 references indexed in Scilit:
- Targeting the PI3-Kinase/Akt/mTOR Signaling PathwaySurgical Oncology Clinics of North America, 2013
- Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarrayEpigenetics, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer CellsFrontiers in Oncology, 2013
- Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranesNature Cell Biology, 2011
- PTEN in liver diseases and cancerWorld Journal of Gastroenterology, 2010
- Requirement of Phosphatidylinositol(3,4,5)Trisphosphate in Phosphatidylinositol 3-Kinase-Induced Oncogenic TransformationMolecular Cancer Research, 2009
- Autophagy and cancer: Dynamism of the metabolism of tumor cells and tissuesCancer Letters, 2009
- Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalitiesNeuroscience, 2008
- Lysosomes and autophagy in cell death controlNature Reviews Cancer, 2005